Immune tolerance induction with recombinant factor VIII in hemophilia A patients with high responding inhibitors

Haematologica

Volumn 91, Issue 4, 2006, Pages 558-561

  Rocino, Angiola ^a   Santagostino, Elena ^b   Mancuso, Maria Elisa ^b   Mannucci, Pier Mannuccio ^b  

^a San Giovanni Bosco Hospital   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

FVIII inhibitors; Hemophilia A; Immune tolerance induction

Indexed keywords

RECOMBINANT BLOOD CLOTTING FACTOR 8;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG HALF LIFE; F8 GENE; GENE; GENE DELETION; GENE INSERTION; GENE MUTATION; HEMOPHILIA A; HUMAN; IMMUNOLOGICAL TOLERANCE; INFANT; INTRON; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; FACTOR VIII; HEMOPHILIA A; HUMANS; IMMUNE TOLERANCE; INFANT; ISOANTIBODIES; MIDDLE AGED; MUTATION;

EID: 33645959486     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Wight J, Paisley S. The epidemiology of inhibitors in haemophilia A: a systematic review. Haemophilia 2003;9:418-35.
2. Di Michele DM. Immune tolerance: a synopsis of international experience. Haemophilia 1998;4:568-73.
3. Brackmann HH. Induced immunotolerance in factor VIII inhibitor patients. Prog Clin Biol Res 1984;150:181-95.
4. Ewing NP, Sanders NL, Dietrich SL, Kasper CK. Induction of immune tolerance to factor VIII in hemophiliacs with inhibitors. JAMA 1988;259:65-8.
5. Nilsson IM, Berntorp E, Zettervall O. Induction of immune tolerance in patients with hemophilia and antibodies to factor VIII by combined treatment with intravenous IgG, cyclophosphamide and factor VIII. N Engl J Med 1988;318:947-50.
6. Gruppo RA, Valdez LP, Stout RD. Induction of immune tolerance in patients with hemophilia A and inhibitors. Am J Pediatr Hematol Oncol 1992;14:82-7.
7. Mauser-Bunschoten EP, Nieuwenhuis HK, Roosendaal G, van den Berg HM. Low dose immune tolerance induction in hemophilia A patients with inhibitors. Blood 1995;86:983-8.
8. Smith MP, Spence KJ, Waters EL, Beresford-Webb R, Mitchell MJ, Cuttler J, et al. Immune tolerance therapy for haemophilia A patients with acquired factor VIII alloantibodies: comprehensive analysis of experience at a single institution. Thromb Haemost 1999;81:35-8.
9. Oldenburg J, Schwaab R, Brackmann HH. Induction of immune tolerance in haemophilia A inhibitor patients by the "Bonn Protocol": predictive parameter for therapy duration and outcome. Vox Sang 1999;77 Suppl 1:49-54.
10. Kreuz W. Immunetolerance induction (ITI) in haemophilia A patients with inhibitors - the choice of concentrate affecting success. Haematologica 2001;86:16-20.
11. Batlle J, Lopez MF, Brackmann HH, Gaillard S, Goudemand J, Humbert J, et al. Induction of immune tolerance with recombinant factor VIII in haemophilia A patients with inhibitors. Haemophilia 1999;5:431-5.
12. Unuvar A, Warrier I, Lusher JM. Immune tolerance induction in the treatment of paediatric haemophilia A patients with factor VIII inhibitors. Haemophilia 2000;6:150-7.
13. Rocino A, Papa ML, Salerno E, Capasso F, Miraglia E, de Biasi R. Immune tolerance induction in haemophilia A patients with high-responding inhibitors to factor VIII: experience at a single institution. Haemophilia 2001; 7:33-8.
14. Verbruggen B, Novakova I, Wessels H, Boezeman J, van den Berg M, Mauser-Bunschoten E. The Nijmegen modification of the Bethesda assay for factor VIII:C inhibitors: improved specificity and reliability. Thromb Haemost 1995;73:247-51
15. Mariani G, Ghirardini A, Bellocco R. Immune tolerance in hemophilia. Principal results from the international registry. Thromb Haemost 1994;72:155-8.
16. Mariani G, Kroner B, for the Immune Tolerance Study Group (ITSG). Immune tolerance in hemophilia with factor VIII inhibitors: predictors of success. Haematologica 2001;86:1186-93.
17. Lenk H. The German National Immune tolerance Registry, 1997 update. Study Group of German Haemophilia Centres. Vox Sang 1999; 77 Suppl 1:28-30
18. DiMichele DM, Kroner BL. The North American Immune Tolerance Study Group. The North American Immune Tolerance Registry: practices, outcomes, outcome predictors. Thromb Haemost 2002;87:52-7.
19. Santagostino E, Gringeri A, Berardinelli L, Beretta C, Muca-Perja M, Mannucci PM. Long-term safety and feasibility of arteriovenous fistulae as vascular accesses in children with haemophilia: a prospective study. Br J Haematol 2003;123:502-6.